Aluminium lithium hydride → (4aR,7aR)-octahydro-1H-cyclopenta[b]pyrazine

HRID 81216Notes

Reaction equation

HRID 81216 reaction equation
[NH:1]1[C:6](=O)[CH2:5][NH:4][C@@H:3]2[CH2:8][CH2:9][CH2:10][C@@H:2]12.[H-].[H-].[H-].[H-].[Li+].[Al+3]>C1COCC1>[NH:1]1[CH2:6][CH2:5][NH:4][C@@H:3]2[CH2:8][CH2:9][CH2:10][C@@H:2]12

Participants

4

Conditions

Temperature
65 °C

Procedure

To a cooled (0° C.) solution of (4aR,7aR)-octahydro-2H-cyclopenta[b]pyrazin-2-one (prepared in analogy to Example 3.120, Steps 1-3) (570 mg, 4.07 mmol) in THF (27 mL) was added dropwise LAH (4.07 mL of a 2.0M solution in THF, 8.14 mmol) over 5 minutes. After the addition was complete, the mixture was capped with a reflux condenser and heated to 65° C. for 14 hours. The resulting mixture was then cooled to room temperature and carefully quenched by the addition of sodium sulfate decahydrate (1.3 g). The reaction mixture was filtered through Celite®, and the filter cake was washed with ethyl acetate. The combined filtrate was dried over magnesium sulfate, filtered, evaporated under reduced pressure and dried in vacuo to give (4aR,7aR)-octahydro-1H-cyclopenta[b]pyrazine. 1H NMR (500 MHz, DMSO-d6) δ 2.75-2.69 (m, 2H), 2.55-2.50 (m, 2H), 2.13-2.07 (m, 4H), 1.66-1.59 (m, 2H), 1.57-1.51 (m, 2H), 1.22-1.12 (m, 2H). Example 5.1 3-(2-((R)-4-acetyl-2-methylpiperazin-1-yl)-4-(5-chloropyridin-3-yl)-3-((trans-4-methyl cyclohexyl)methyl)-3H-imidazo[4,5-c]pyridin-6-yl)-1,2,4-oxadiazol-5(4H)-one

Workup

  1. additionAfter the addition
  2. customthe mixture was capped with a reflux condenser
  3. temperatureThe resulting mixture was then cooled to room temperature
  4. customcarefully quenched by the addition of sodium sulfate decahydrate (1.3 g)
  5. filtrationThe reaction mixture was filtered through Celite®
  6. washthe filter cake was washed with ethyl acetate
  7. dry with materialThe combined filtrate was dried over magnesium sulfate
  8. filtrationfiltered
  9. customevaporated under reduced pressure
  10. customdried in vacuo

Sources & evidence

ORD record
ord-5dd3d9c339fe496cb1708df7766b6f4a
Source dataset
uspto-grants-2014_09
Patent number
US08846657B2

Reaction notes

Loading…